Guangdong Medical Insurance Bureau issued a document: Hospitals give priority to using domestic medical consumables

Hospitals give priority to using domestic consumables.
On May 10, according to the Guangdong Provincial Medical Insurance Bureau, they put forward co-organizing opinions on strengthening the independent research and development capabilities of the medical device industry, and released a major signal
.
The content pointed out that a coordination mechanism between medical insurance payment standards and centralized procurement of medical consumables will be established and improved, and the development and use of domestic high-quality medical consumables will be supported by formulating medical insurance payment standards for selected and non-selected varieties of medical consumables in centralized procurement, and promote the development of the domestic medical consumables industry
.
(Screenshot source: Guangdong Provincial Medical Insurance Bureau) It is reported that in December 2020, Guangdong Province issued the "Notice on the Implementation of the National Medical Security Administration's Opinions on the National Organization for the Centralized Procurement of Coronary Stents and the Use of Supporting Measures".
(Yueyibaofa [2020] No.
42), requires the listed medical insurance departments at all levels to do a good job in formulating the payment standards for coronary stent medical insurance
.
The selected price of the selected species in the centralized procurement of coronary stents organized by the state is used as the payment standard, and the full amount is included in the payment scope of the medical insurance fund
.
Set the highest medical insurance payment standard for non-selected varieties, and take corresponding measures based on local conditions to gradually adjust the payment standard within two years so that it does not exceed the highest selected price
.
The listed medical insurance bureaus at the prefecture level formulate payment standards for the selected varieties in the centralized procurement of coronary stents organized by the state, regulate the medical insurance payment of corresponding medical consumables, and encourage medical institutions to give priority to using domestic medical consumables selected in the national centralized procurement
.
Increasing the chance of selecting domestic consumables.
In this reply of the Guangdong Provincial Medical Insurance Bureau on May 10, it is pointed out that eligible medical consumables will be included in the scope of medical insurance payment..
In March 2021, Guangdong Province issued the "Guangdong Province Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Medical Consumables Catalog (2021)" (Yueyibaofa [2021] No.
14), which will provide medical services with high clinical value and excellent economic evaluation.
Consumables are included in the scope of medical insurance payment, further clarifying the scope of medical insurance payment for medical consumables.
When the insured uses the medical consumables in the catalog according to regulations, the medical insurance fund will pay according to the regulations, which reduces the burden on medical expenses of the insured and promotes the development of the domestic medical consumables industry.

.
(Screenshot Source: Insurance Bureau of Guangdong Province) for the tender procurement mechanism in support of alternative aspects of the development and use of domestic supplies, domestic supplies, the Guangdong Provincial Medical Insurance Bureau pointed out: First, the introduction of "Guangdong Provincial Health and Social Security Bureau on doing drugs and medical supplies procurement "Guiding Opinions on Work" (Guangdong Medical Insurance Regulation [2020] No.
2), requires that the medicines and medical consumables used by public medical institutions at all levels in the province be uniformly purchased on the procurement platform.
Those who have obtained the official production approval issued by the State Drug Administration Products can be registered for online trading on the provincial platform, Guangzhou platform, and Shenzhen platform, and medical institutions can purchase and use online according to clinical needs, and gradually realize "tradable online and available across the province" and reduce corporate sales costs
.
For the types of medical consumables that are not available on the procurement platform, such as emergency approvals or urgent shortages in response to public health emergencies, no actual transactions or other reasons that cause difficulty in procurement, are clinically necessary, and have very little clinical use, etc.
, Medical institutions can independently negotiate purchases within 5% of the total annual purchase amount to promote domestic medical consumables to be put into clinical use as soon as possible
.
The second is to implement the same group bidding policy for domestic medical consumables and imported medical consumables in the formulation of the rules for the centralized procurement of medical consumables in Guangdong Province to increase the price advantage of domestic medical consumables and increase the chance of domestic medical consumables being selected
.
A few days ago, the Guangdong Provincial Health Commission issued the "Announcement on the List of Imported Products of Provincial Health Institutions in 2021", mainly to promote the management of the list of imported products purchased by the provincial health institutions, simplify procedures, and improve government procurement of imported products.
effectiveness
.
On March 11, the People's Government of Guangzhou City, Guangdong Province issued a notice on "Optimizing the Administration of Government Procurement of Imported Products", clarifying that Guangzhou will start the optimization of the administration of government procurement of imported products from March 1, 2021
.
Notification requirements: closely review the entry points of imported products, and strictly review whether there is over-standard procurement, the necessity, irreplaceability, economy, and efficiency of imported products
.
At the same time, when purchasing imported products, it is necessary to demonstrate highlighting the comparison between imported and domestic products, and emphasize the role of procurement experts in the evaluation of imported products.
The imported products to be purchased belong to imported products that have similar domestic products in China but cannot meet the actual needs.
In addition to the required materials, it is also necessary to provide a comparison table of technical parameters, functionality, etc.
of domestic similar products and imported products, as well as meeting minutes and records of the unit's "three important and one large" issues
.
It is required that the purchase of imported products is agreed to expand the scope of product procurement.
In the procurement information announcement and bidding documents, domestic product suppliers and agent imported product suppliers are allowed to participate at the same time
.
  　　The gap in domestic equipment is still large.
  　　Recently, "China Medical Equipment" released the " Analysis Report of China's Medical Equipment Import Substitution Products"
.
The report quantitatively analyzes the localization rate of medical devices and reflects the current status of China's import substitution of medical device products
.
The report is mainly in accordance with the 2017 version of the "Medical Device Classification Catalogue" standard, respectively, to statistically compare the number of domestic and imported products from 2017 to 2020
.
This data analysis covers 1111 secondary product categories, covering 125,176 domestic products and 13,904 imported products
.
Analysis dimensions include industry background data (medical equipment market size, enterprise, The number of products and professional service organizations, the number of enterprise patents and innovation approved products, etc.
); and the data on imported substitute products (as well as the range of localization rate and the number of products, the number of domestically-made high-proportion categories, the number of domestically-made products that have zero breakthroughs, and the proportion of domestically-made products has increased The distribution of categories, the catalog of imported alternative products, etc.
).
The overall data are as follows:     　　As of the end of 2020, there are a total of 60 secondary product categories with a localization rate of 0%, accounting for 5.
4%; a total of 334 secondary product categories with a localization rate of 0-70%, accounting for 30.
1%; the localization rate is over 70% There are a total of 717 secondary product categories, accounting for 64.
5%
.
In other words, 94.
6% of secondary product categories have achieved varying degrees of import substitution
.
Among them, the number of varieties with a localization rate higher than 50% during the period 2017-2020 (the number of imported alternative superior products) has increased year by year, from 518 in 2017 to 881 in 2020, and the number of imported alternative superior products has increased in the past four years.
More than 70%
.
At the same time, the number of varieties with a localization rate of 0% during 2017-2020 has been decreasing year by year
.
2017 Quantity localization rate of two categories 0% up to 166, while in 2020 decreased to 60, increasing the number of products in various fields to achieve a breakthrough, "from 0-1" of
.